| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |